ACTION teens
Learn more about a study that aims to improve obesity management and treatment of adolescents living with obesity.
Rethink Obesity is a global platform for healthcare professionals to discover the latest resources on approaching obesity management and creating a person-centered and empathetic dialogue with patients.
Obesity impacts 813 million adults (aged 20 years and over), a number predicted to rise to 1.5 billion by 2030.1 It has a substantial health impact with 200+ possible complications affecting many organs and systems.2,3 Cardiovascular disease is the leading cause of mortality in people with obesity.4 There is clear association between BMI, hypertension (high blood pressure) and heart failure. For example, the prevalence of hypertension increases with increasing BMI.5
The number of people living with obesity continues to rise, highlighting the need to provide medical professionals with evidence-based tools to tackle the growing global obesity epidemic effectively.
By understanding the scientific principles that underlie the development of obesity and identifying challenges in an evidence-based manner, barriers to effective obesity management can be overcome. Rethink Obesity® aims to provide this science-based information, in an easily accessible manner, to healthcare professionals so they are able to enhance their clinical practice and achieve sustainable results for their patients living with obesity.
Watch the CVD and Obesity video above to learn more about the complications of obesity.
At Novo Nordisk we want to provide Healthcare Professionals (HCPs) with scientific information, resources and tools. To get started find your local HCP portal by following the link below.
Access downloadable resources for obesity. These are designed for you and your patients to optimise obesity management.
HQ23OB00411, Approval date: November 2023
Disclaimer: All images used are stock photos. Posed by models
The site you are entering is not the property of, nor managed by, Novo Nordisk. Novo Nordisk assumes no responsibility for the content of sites not managed by Novo Nordisk. Furthermore, Novo Nordisk is not responsible for, nor does it have control over, the privacy policies of these sites.
At Novo Nordisk we want to provide Healthcare Professionals (HCPs) with scientific information, resources and tools.